Pediatric Dermatology

Latest News


CME Content


Satisfaction guaranteed

Berlex Laboratories is offering a money-backguarantee program for patients using its azelaic

Washington - A ceramide-dominant barrier repair moisturizer (TriCeram) is a valuable adjuvant in the treatment of atopic dermatitis, according to the results of a study presented by University of California, San Francisco dermatology researchers at the annual meeting of the Society for Investigative Dermatology.

San Francisco - Molecular definition of cancer antigens has opened new possibilities for developing effective adjuvant melanoma immunotherapies, according to Steven A. Rosenberg, M.D., Ph.D.

Washington - A conditioned, growth factor-containing nutrient solution derived from the manufacture of bioengineered skin appears to be a unique, effective topical treatment for rejuvenation of cutaneous photodamage, according to studies presented at the annual meeting of the Society for Investigative Dermatology.

VIENNA - The ascomycin derivative pimecrolimus (ASM 981, Elidel) - currently in Phase III trials for the treatment of atopic dermatitis (topical) and psoriasis (oral) - exhibits skin-specific anti-inflammatory activity and has low potential for immunosuppression in both its topical and oral formulations.

Beauty benefit: Legs that don't look like roadmaps. Health bonus: Reduced risk of pain, swelling, blood clots, and skin ulcers.

Aging slowdown

The newest anti-aging ingredient to hit drugstore aisles is N6-furfuryladenine(aka kinetin), a substance found in the leaves of green plants.

Natural and photoinduced skin aging appear far more similar than once thought; similar remedies to photoaging suggested

Avoiding injury to physicians and patients comes from understanding of laser operation